Business Wire

TEMPO Commencing a Formal Process for a Significant Investment

Jaa

The Board of Directors of Nýherji hf. has hired AGC Partners, a global investment bank headquartered in Boston, MA, to initiate a formal process for a significant investment in TEMPO ehf, a wholly-owned Nýherji subsidiary.

Tempo’s solutions enable organizations to plan, optimize, and manage JIRA resources, budget and track project costs, and track and report time for back-office efficiency. The Company’s solutions solve key “white-collar” enterprise pain points around JIRA developer productivity, resource optimization, and time tracking as it unobtrusively collects data on calendars and tool usage in the background for the pre-population of time sheets. Tempo’s time management and budgeting tools have become essential products in the JIRA ecosystem and are well received by CIOs and CFOs looking to gain better clarity into time and resource usage and cost within their organization. Further, Tempo is consistently one of the highest rated and most downloaded add-on application within the Atlassian Marketplace.

Nýherji CEO, Finnur Oddsson, "Tempo's continued growth and success has been fueled by the team‘s singular focus on building a world-class product and organization. Following the development of Tempo Cloud for JIRA and the migration of over 7,000 customers over to Tempo's new cloud services on top of AWS (Amazon Web Services), a number of exciting growth opportunities have opened up, including integration with other cloud services in addition to JIRA by Atlassian. We think now is the right time to enhance Tempo‘s growth with a sophesticated investor that can help take the Company to the next level. For the past year, AGC Partners has advised on the strategic aspects of Tempo's operations and growth strategy and assisted with the general presentation of the Tempo to investors in the technology sector. AGC Partners will now commence Tempo's formal investment process, aiming to attract a financial partner with extensive experience in growing software companies internationally. We believe this will best enable the continuation of product development at Tempo, its revenue growth, and value for owners, employees and customers."

Nýherji hf.

Nýherji is one of Iceland’s largest providers of information technology solutions, offering hardware, software, consultancy, and technical services. Nýherji has over 1,000 clients and helps our customers achieve the best results for their businesses with the help of IT services through our staff's expertise and quality service. Nýherji hf. is registered in NASDAQ OMX Iceland hf. under the symbol NYHR.

TEMPO

Tempo is a leading provider of time management and budgeting software, transforming time and resource tracking for increased back-office efficiency with smart work management solutions. Tempo's customers are companies around the globe, from startups to Fortune 500 companies including BMW, Pfizer, HomeAway, PayPal, Hulu, Dell, Mercedes Benz, Starbucks, and Disney. Tempo is a whole-owned subsidiary of Nýherji Group. Tempo employs around 100 staff, both in Iceland and in North America. Visit www.tempo.io for more information.

For the attention of investors

Nýherji Group wishes to notify investors that statements made in this press release may be based on the current expectations, forecasts and assumptions of the company's executives and not facts subsequently verifiable by the publication of this press release. Such statements are naturally subject to future risks and uncertainties. We wish to notify investors that a number of factors could cause the company's business environment to differ materially from current expectations as assumed in the press release. This press release will not be revised after its publication in this regard. Any statement made in this press release is valid only at the point of its publication, and its validity is restricted in accordance with this clause.

Contact information

Further information
Finnur Oddsson, Nýherji CEO
+354 862 0310
fo@nyherji.is,
or
Gunnar Petersen, Nýherji CFO
+354 825 9001
gp@nyherji.is
or
Frederick Joseph at AGC Partners
+001 617 261 4150
fjoseph@agcpartners.com.

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

New Guidance From ADA and EASD Recommends Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Patients with Type 2 Diabetes16.10.2018 16:15Tiedote

As the European distributor of INVOKANA ® (canagliflozin) and VOKANAMET ® (canagliflozin and metformin) Mundipharma welcomes the news that SGLT2i’s, including canagliflozin, have now been included as an important treatment option in the newly published 2018 ADA/EASD Consensus Report in the early management of T2DM patients with established ASCVD, HF, CKD and also in patients without cardiovascular disease (CVD) especially where there is a compelling need to minimize weight gain or promote weight loss or a need to minimize the risk of hypoglycaemia. The new guidance was co-published in Diabetologia, the journal of EASD, and Diabetes Care, the journal of the ADA, during the annual meeting of EASD in Berlin, Germany on October 5.1 Updates to the guidance took into consideration recent evidence from large CV outcome trials (CVOTs), which included the CANVAS programme, the largest completed and published CV outcomes trial to date for an SGLT2i, which has shown that canagliflozin reduces the

Brightree Launches First Patient App for HME16.10.2018 16:05Tiedote

Brightree®, the leading provider of cloud-based software to help post-acute care companies improve business performance and patient outcomes, announced today from Medtrade the release of its new Patient Hub to personalize the patient experience and increase revenue for home medical equipment (HME) providers. Patient Hub is a patient engagement app that automates and simplifies how HME providers connect with their patients. It eliminates the need for multiple web portals and consolidates all patient interactions into one secure platform. By improving ease of engagement and automation, Patient Hub empowers care, frees up resources and creates opportunities to accelerate cash flow. The Patient Hub app allows providers to automate simple, repetitive processes such as sending out appointment reminders and requests for insurance updates, or delivering order status and tracking updates. Patients can initiate and complete tasks as well, including updating account information, reordering suppli

KYMCO Announces Entry Into India With Ionex16.10.2018 15:40Tiedote

KYMCO announces its official entry into India with its game-changing Ionex electric scooter total solution. In partnership with Twenty Two Motors, an Indian company that focuses on developing advanced connected electric vehicles, KYMCO is set to revolutionize the two-wheeler sector in India by bringing the new era of electric scooters and building the open energy platforms long awaited by Indian customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016005636/en/ Allen Ko, Chairman, KYMCO (Photo: Business Wire) India is the largest two-wheeler market in the world. The Indian government is actively promoting green movement through policies that encourage the use of electric vehicles as well as the establishment of EV infrastructure. The latest ‘National E-Mobility Programme’ aims to shift one third of petrol and diesel vehicles to electric by 2030. The government has a strong motivation for “go electric, go green” revol

Fujitsu to Demonstrate New “Super-Slim” Washable RFID Linen Tags at the EXPOdetergo 18th International Exhibition in Milan, Italy16.10.2018 15:00Tiedote

Fujitsu Frontech North America Inc., a leader in innovative technology and front-end solutions, has announced today that Fujitsu has developed a new line of washable UHF RFID tags only 7 millimeters wide, 30% smaller than current tags, allowing them to be more easily inserted into the seams of washable items. Fujitsu will debut the new “super-slim” tags, as well as their WT-A533 Linen tags and WT-A533L Fashion tags, at the EXPOdetergo 18th International Exhibition, Hall 1 booth # V10, on October 19-22, 2018, at the Fiera Milano Convention Center, Milan, Italy. The Fujitsu “super-slim” washable RFID Linen tags are targeted for availability in the first quarter of 2019. “Fujitsu has been creating RFID solutions for over 20 years. Our engineering and design teams possess sophisticated engineering, design and antenna optimization intellectual property,” says Michi Sugawara, President and CEO of Fujitsu Frontech North America Inc. “By combining this know-how plus our skills in high-volume,

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.16.10.2018 15:00Tiedote

Quotient Sciences, a leading drug development services organization, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing. The Garnet Valley site will focus on developing small molecule oral drug products, supporting development programs from the preclinical stage through to clinical proof-of-concept. Seamless scale-up to late-phase manufacturing and commercial product supply will continue at Quotient’s nearby Chelsea Parkway facility. “Our new facility was built in response to increasing customer demand for our early-phase formulation development and clinical trial manufacturing services,” said Mark Egerton, Ph.D., CEO of Quotient Sciences. “The site was specifically designed to optimize our ability to work with highly potent

PotNetwork Holdings, Inc. Releases PCAOB Fully Audited and Reviewed Financial Statements under Its Registration as an SEC Reporting Company16.10.2018 15:00Tiedote

PotNetwork Holdings, Inc. (OTC Pink:POTN) has successfully filed its Form 10 registration statement with the U.S. Securities and Exchange Commission (“SEC”), which included independent third party PCAOB (“Public Company Accounting Oversight Board”) auditor certification of its financial performance for all of 2017 and verification of its financial results through the first 6 months of 2018. Going forward, all such financial information will be PCAOB auditor verified. Through submission of the filing, the Company has voluntarily become subject to the full disclosure requirements of the SEC for reporting companies, and the Company must have each quarter’s fiscal performance PCAOB auditor reviewed and its year-end statements fully audited by a PCAOB member firm. Now as a reporting company, PotNetwork Holdings, Inc. qualifies for uplisting to the OTCQB market tier. The PCAOB sets the auditing standards for its member firms, and performs inspections of member firm audits of public companies

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme